Reference · The defining fact
Zinc Thymulin: Why Thymulin Depends on Zinc
One zinc ion, one peptide, a 1:1 ratio. The metal is not a cofactor on the side — it is what gives thymulin its active shape. The chemistry, the assay evidence, and the human zinc-status link.
In plain English
Zinc thymulin is just thymulin with its zinc attached — and that attachment is everything. The nine-amino-acid chain on its own does almost nothing; clip one zinc atom onto it, in a strict one-to-one pairing, and it folds into the shape that works. Pull the zinc back off and it goes quiet again. Scientists proved this by stripping the metal away with a chelator (a molecule that grabs metal ions) and watching the activity disappear, then adding zinc back and watching it return. This page explains that switch, and why, in people, thymulin levels rise and fall with how much zinc the body has. It is a research peptide; nothing here is dosing advice.
Thymulin and Serum Thymic Factor (FTS)
Thymulin and serum thymic factor are two states of the same molecule. Serum thymic factor — FTS, facteur thymique sérique — is the original name, given to the peptide isolated from serum before its metal dependence was understood [1]. When investigators showed that the biologically active form carried a bound zinc ion, they coined the name thymulin for that zinc-bound active complex (FTS-Zn) [1].
So the serum thymic factor (FTS) is the broader peptide identity, and thymulin is specifically its active, zinc-loaded form. The zinc-free chain is sometimes called apothymulin; it is biologically inactive. Keeping these names straight matters, because older papers use FTS where newer ones use thymulin for the same nonapeptide [1][2].
The conformational switch
Zinc does not merely sit beside thymulin — it shapes it. Nuclear magnetic resonance work shows that zinc binding induces a specific three-dimensional conformation in the nonapeptide, and the zinc-free apopeptide does not adopt that active conformation [2]. Activity depends on the metal bound in an equimolecular (1:1) ratio [1][2].
This is why thymulin is classed as a metallopeptide. The bound zinc ion is a structural determinant of function, not an optional accessory. The practical consequence is direct: anything that removes or sequesters the zinc removes the activity. Elevated metallothionein — zinc-binding proteins that rise in aging — can sequester zinc and reduce thymulin activation, one proposed link between zinc status and age-related decline in thymulin activity [2].
The rosette-assay evidence
The zinc requirement was demonstrated by chelation and repletion. Treating serum thymic factor with the chelator Chelex 100 abolished its biological activity in the rosette assay, a classical immunological bioassay historically used to measure FTS/thymulin activity; activity was restored by zinc salts, and, to a lesser extent, by certain other metals, with a 1:1 metal-to-peptide molar ratio giving optimal activation [1]. Atomic absorption spectrometry confirmed the bound metal [1].
That single chelation–repletion experiment is the empirical foundation of the whole zinc-thymulin story: strip the metal, lose the function; restore the metal, restore the function. It is what justified naming the zinc-bound form as a distinct, active species [1].
Serum thymulin as a zinc-status indicator in humans
The zinc dependence is measurable in people. In three models of mild human zinc deficiency — two dietary-restriction volunteers and adults with and without sickle-cell anemia — serum thymulin activity was decreased despite normal plasma zinc and was corrected by in-vivo and in-vitro zinc supplementation, alongside reversible shifts in T-cell subsets and IL-2 activity [3]. Because plasma zinc can read normal in mild deficiency, serum thymulin activity served as a more sensitive functional indicator of zinc status [2][3].
This human finding is one of the most firmly established in the thymulin literature, and it is a finding about zinc status and thymulin activity — not a treatment claim. It also illustrates the interpretive challenge the field flags repeatedly: because activity is strictly zinc-dependent, thymulin-specific outcomes are entangled with zinc availability [2].
Why does thymulin need zinc to work?
Zinc binding in a 1:1 ratio creates the specific three-dimensional conformation required for biological activity [2]. Chelating the zinc abolishes activity in the rosette assay, and adding zinc back restores it [1]. The zinc-free apopeptide is inactive; the metal is a structural determinant of the active shape, not an external cofactor acting at a distance.
Is thymulin the same as serum thymic factor (FTS)?
They are two states of the same peptide. FTS (facteur thymique sérique) is the original name for the serum-isolated nonapeptide; thymulin is the name coined for its biologically active, zinc-bound form (FTS-Zn) [1]. The zinc-free form is inactive, and the zinc-bound form is thymulin — same chain, different metal state [1][2].